Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease. Pusic I, Lee C, Veeraputhiran M, Minor C, et al. Bone Marrow Transplant 2023 Dec 9. doi: 10.1038/s41409-023-02165.

Read + Share

Amedeo Smart

Independent Medical Education

Pusic I, Lee C, Veeraputhiran M, Minor C, et al. Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease. Bone Marrow Transplant 2023 Dec 9. doi: 10.1038/s41409-023-02165.
PMID: 38071272